Share on LinkedInShare on LinkedIn

ARTICLE · 02 SEPTEMBER 2022

IP High Court Case: Determination Of Inventive Step Regarding Unexpected Advantageous Effects

Title of Invention: PTH-containing therapeutic/prophylactic agent for osteoporosis, characterized in that PTH is administered once a week in a unit dose of 100-200 units.

JapanIntellectual Property

Outline of the Court Case

IPHC Case Number: 2020(Gyo-Ke) 10071

Case Type: Revocation Action against the JPO Decision of Invalidation Trial

Judgement Date: February 2, 2022

Plaintiff: Sawai Pharmaceutical Co., Ltd. (Petitioner of Invalidation Trial)

Defendant: Asahi Kasei Pharma (Patentee)

Japanese Patent No.: 6150846 (Present patent)

Title of Invention: PTH-containing therapeutic/prophylactic agent for osteoporosis, characterized in that PTH is administered once a week in a unit dose of 100-200 units.

Summary of the Judgement:

  • The IPHC dismisses the JPO Decision of Invalidation Trial that found inventive step in the present invention. (JPO Invalidation Trial Number: 2018-800080)

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from